FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

636811000001106: Megace 160mg tablets (Bausch & Lomb UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1265391000001111 Megace 160mg tablets (Bausch & Lomb UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1265401000001114 Megace 160mg tablets (Bausch & Lomb UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
17333101000001119 Megace 160mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17333201000001114 Megace 160mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37805401000001118 Megace 160mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
95573101000001112 Megace 160mg tablets (Swedish Orphan Biovitrum Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Is a Product containing precisely megestrol acetate 160 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has active ingredient Megestrol acetate false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has active ingredient Antineoplastic agent false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Is a Megace true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has specific active ingredient Megestrol acetate true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Is pack of False Megace 160mg tablets (Bausch & Lomb UK Ltd) Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Has AMP True Megace 160mg tablets (Bausch & Lomb UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start